Skip to content

D3 20-4900010

by Diagnostic Hybrids, Inc.

Ref 20-4900010Model D3

D3 20-4900010 is an in vitro diagnostic device (EU IVDD general IVD; FDA Class I; FDA product code OHQ, Multi-analyte controls unassayed) made by Diagnostic Hybrids, Inc., registered in EUDAMED on 22 Oct 2026 (Basic UDI-DI B-30014613338611) and listed in FDA GUDID since 19 Apr 2019 (UDI-DI 30014613338611), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-30014613338611 Basic UDI-DI 30014613338611UDI-DIDate22 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number30014613338611 UDI-DI Date19 Apr 2019ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
CMV Control Stock
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-30014613338611 registered 22 Oct 2026 Active
  • FDA GUDID UDI-DI 30014613338611 listed 19 Apr 2019 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Timeline

2 dated events

  1. Listed FDA GUDID 30014613338611
  2. Registered EUDAMED B-30014613338611

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
D3 CMV Training Stock EUDAMED
D3 GUDID
Generic name
Cytomegalovirus (CMV) antigen IVD, control
Device name
CMV Training Stock
Model / Ref / Catalog
20-4900010, D3
Primary DI / UDI-DI
30014613338611
Basic UDI-DI
B-30014613338611
FDA product code
OHQ
EMDN code
W0105040299 Cmv reagents - other
GMDN term
Cytomegalovirus (CMV) antigen IVD, control
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
862.1660
EU registration type
Legacy device (under a directive)
EU market of registration
Austria
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under CYTOMEGALOVIRUS.

Other devices from Diagnostic Hybrids, Inc.

See all devices from Diagnostic Hybrids, Inc. →

Properties

  • Single use
  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • Professional testing
  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (18, all answered No)